Sterilization Technology Kills Hospital Bedbugs
|
By HospiMedica International staff writers Posted on 08 May 2013 |

Image: The AsepticSure portable sterilization system (Photo Courtesy of Medizone International).
A new hospital sterilization system eradicates highly drug-resistant bacteria as well as a problem increasingly plaguing hospitals—bedbugs.
The AsepticSure sterilization system is a portable, affordable, easily operated system that is placed in the center of the room scheduled to be cleaned. The room vents and doors are then sealed with a cleanly removable adhesive tape product. The system is then turned on from outside of the room through a remote wireless computer interface, and the room is filled with a patented ozone-based gas formula with specific humidity and charge strength.
Following the charge period, the sterilization process is remotely turned off and a separate technology is employed that restores the atmosphere inside the room. The end result leaves the treated room sterile of pathogens with a sweet, fresh oxygen-charged atmosphere. Turnaround time for reuse of rooms up to 113 cubic meters in size is 80–90 minutes; this includes decontamination of carpets, drapes and medical equipment, all to the 6 log sterilization standard. The AsepticSure sterilization system is a product of Medizone International (San Francisco, CA, USA).
“The bedbugs, and particularly the eggs of bedbugs, are even harder to kill than the spores of the bacteria,” said Professor Dick Zoutman, MD, an infectious disease specialist at Queen’s University (Ontario, Canada), and chief medical officer of Medizone International. “Medizone is now working to adapt the system to kill bedbugs in a faster and more effective manner, both for hospitals and other settings as well.”
More than a third of pest-management companies treated bedbug infestations in hospitals in 2012, 6% more than the year before and more than twice as many as in 2010, according to a survey released today by the National Pest Management Association (Fairfax, VA, USA). While bedbugs do not transmit infections to humans, their bites can lead to secondary infections when victims scratch, opening themselves up to bacteria. This is especially problematic in hospitals, where there is a greater likelihood of infection with Methicillin-resistant Staphylococcus aureus (MRSA).
Related Links:
Medizone International
National Pest Management Association
The AsepticSure sterilization system is a portable, affordable, easily operated system that is placed in the center of the room scheduled to be cleaned. The room vents and doors are then sealed with a cleanly removable adhesive tape product. The system is then turned on from outside of the room through a remote wireless computer interface, and the room is filled with a patented ozone-based gas formula with specific humidity and charge strength.
Following the charge period, the sterilization process is remotely turned off and a separate technology is employed that restores the atmosphere inside the room. The end result leaves the treated room sterile of pathogens with a sweet, fresh oxygen-charged atmosphere. Turnaround time for reuse of rooms up to 113 cubic meters in size is 80–90 minutes; this includes decontamination of carpets, drapes and medical equipment, all to the 6 log sterilization standard. The AsepticSure sterilization system is a product of Medizone International (San Francisco, CA, USA).
“The bedbugs, and particularly the eggs of bedbugs, are even harder to kill than the spores of the bacteria,” said Professor Dick Zoutman, MD, an infectious disease specialist at Queen’s University (Ontario, Canada), and chief medical officer of Medizone International. “Medizone is now working to adapt the system to kill bedbugs in a faster and more effective manner, both for hospitals and other settings as well.”
More than a third of pest-management companies treated bedbug infestations in hospitals in 2012, 6% more than the year before and more than twice as many as in 2010, according to a survey released today by the National Pest Management Association (Fairfax, VA, USA). While bedbugs do not transmit infections to humans, their bites can lead to secondary infections when victims scratch, opening themselves up to bacteria. This is especially problematic in hospitals, where there is a greater likelihood of infection with Methicillin-resistant Staphylococcus aureus (MRSA).
Related Links:
Medizone International
National Pest Management Association
Latest Patient Care News
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
Channels
Artificial Intelligence
view channelCritical Care
view channel
AI Stethoscope Spots Heart Valve Disease Earlier Than GPs
Valvular heart disease affects more than half of people over 65, yet it often goes undiagnosed until symptoms become severe. In advanced stages, untreated cases can carry a mortality risk of up to 80%... Read more
Bioadhesive Patch Eliminates Cancer Cells That Remain After Brain Tumor Surgery
Glioblastoma is the most common and aggressive form of brain tumor, characterized by rapid growth, high invasiveness, and an extremely poor prognosis. Even with surgery followed by radiotherapy and chemotherapy,... Read moreSurgical Techniques
view channel
Neural Device Regrows Surrounding Skull After Brain Implantation
Placing electronic implants on the brain typically requires removing a portion of the skull, creating challenges for long-term access and safe closure. Current methods often involve temporarily replacing... Read more
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







